To explore whether FLT3 or DNMT3A mutations affect other molecules of AML, we examined CD33 and CD123 expressions of SKM‐1, SKM‐1‐FLT3 and SKM‐1‐DNMT3A‐SC2 cells. The gene discussed is FLT3; the disease is acute myeloid leukemia.